Key facts
- This page summarizes Timothy E. Baxter's Form 4 filing for PAVmed Inc. (PAVM).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 23 Feb 2024, 16:49.
Timothy E. Baxter - 22 Feb 2024 Form 4 Insider Report for PAVmed Inc. (PAVM)
- Reporting relationship
- Director
- Issuer ticker
- PAVM
- Reported as of
- 22 Feb 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 Feb 2024, 16:49:15 UTC
- Prior SEC filing
- 02 Feb 2023
- Next SEC filing
- 04 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael A. Gordon, by power of attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Timothy E. Baxter filed Form 4 for PAVmed Inc. (PAVM) on 23 Feb 2024.
Change
- Previous filing in this sequence was filed on 02 Feb 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PAVM
transaction
Common stock
Award
- Transaction value
- Shares
- +65,000
- Change %
- Price
- Shares after
- 65,000
- Date
- 22 Feb 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The issuer granted 65,000 shares of restricted stock to the reporting person pursuant to its long term incentive equity plan.